Boutique asset manager specializing in tax-advantaged and alternative credit strategies for institutional and high-net-worth clients, with an emphasis on cash-flow-oriented private credit and structured financing. Sugar Maple Asset Management, LLC positions itself as a nimble allocator across direct lending, specialty finance and collateralized credit, leveraging bespoke underwriting, portfolio construction and risk-management processes to target income generation and capital preservation. Relevant to allocators seeking diversified yield exposure in illiquid credit markets.
Boutique asset manager specializing in tax-advantaged and alternative credit strategies for institutional and high-net-worth clients, with an emphasis on cash-flow-oriented private credit and structured financing. Sugar Maple Asset Management, LLC positions itself as a nimble allocator across direct lending, specialty finance and collateralized credit, leveraging bespoke underwriting, portfolio construction and risk-management processes to target income generation and capital preservation. Relevant to allocators seeking diversified yield exposure in illiquid credit markets.
Focuses on tax-advantaged and alternative credit mandates, emphasizing cash-flow-driven private credit, structured financings and specialty finance. Pursues nimble, income-oriented capital deployment across direct lending and collateralized credit with a bias toward bespoke underwriting, conservative leverage and scenario-based stress testing. Portfolio construction blends yield generation with capital preservation via diversified exposures, tranche selection and active liquidity management. Targets institutional and high-net-worth allocators seeking durable, illiquidity premia; decision-making prioritizes downside protection, sponsor alignment and repeatable risk-adjusted income over short-term market timing.
Focuses on tax-advantaged and alternative credit mandates, emphasizing cash-flow-driven private credit, structured financings and specialty finance. Pursues nimble, income-oriented capital deployment across direct lending and collateralized credit with a bias toward bespoke underwriting, conservative leverage and scenario-based stress testing. Portfolio construction blends yield generation with capital preservation via diversified exposures, tranche selection and active liquidity management. Targets institutional and high-net-worth allocators seeking durable, illiquidity premia; decision-making prioritizes downside protection, sponsor alignment and repeatable risk-adjusted income over short-term market timing.
| Trades 1090 | Longs Won 609/1090 55% | Profit Factor 5.49 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $235,876.69 |
| Average Win $64,272.35 | Best Trade (Oct 15) $5.72M | Sharpe Ratio -47.68 |
| Average Loss -$14,815.29 | Worst Trade (Oct 15) -$1M | Z-Score 0.43 (33.36%) |
| Commissions $0 | Avg. Trade Length 8m 2w 2d | Expectancy $29,875.39 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 11,905 | 10,714 | 9,524 | 8,333 | 7,143 | 5,952 | 4,762 | 3,571 | 2,381 | 1,190 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,493 | $626,362.06 | $852,942.55 | - | $226,580.49 | 36.17% | -0.241% |
ABBV AbbVie Inc. | 55,355 | $10.08M | $15.84M | - | $5.75M | 57.05% | +1.537% |
ABT Abbott Laboratories | 67,028 | $7.61M | $7.02M | - | -$597,034.72 | -7.84% | +2.301% |
ADMA Adma Biologics Inc. | 16,300 | $137,759 | $174,899 | - | $37,140 | 26.96% | +3.772% |
AGG iShares Core U.S. Aggregate Bond ETF | 10,710 | $1.06M | $1.02M | - | -$41,184.21 | -3.87% | +0.638% |
AMZN Amazon.com Inc | 3,413 | $663,208.67 | $865,673.32 | - | $202,464.65 | 30.53% | -0.173% |
APP AppLovin Corporation Class A Common Stock | 2,194 | $637,203 | $605,960.86 | - | -$31,242.14 | -4.9% | +5.34% |
AQST Aquestive Therapeutics Inc. | 117,060 | $608,102.56 | $487,554.9 | - | -$120,547.66 | -19.82% | -9.653% |
ASML ASML Holding N.V. New York Registry Shares | 175 | $231,145 | $287,295.75 | - | $56,150.75 | 24.29% | -0.504% |
| AUGP AUGP | 13,500 | $411,090 | $411,090 | - | - | - | 0.0 |
BALT Inn Defined Wealth Shield Mutual Fund | 13,500 | $443,070 | $472,972.5 | - | $29,902.5 | 6.75% | +0.043% |
BKDV BNY Mellon Dynamic Value ETF | 135,525 | $4.23M | $4.67M | - | $441,090.98 | 10.44% | +0.437% |
CLOI VanEck CLO ETF | 91,294 | $4.82M | $4.83M | - | $608.76 | 0.01% | +0.047% |
CNEQ Alger Concentrated Equity ETF | 30,541 | $1.2M | $1.19M | - | -$3,704.72 | -0.31% | -0.926% |
CPSM Calamos S&P 500 Structured Alt Protection ETF – May | 39,000 | $1M | $1.16M | - | $154,380 | 15.38% | +0.169% |
DOG ProShares Short Dow30 | 63,000 | $1.48M | $1.37M | - | -$104,895 | -7.09% | -0.886% |
FAAA Fidelity AAA CLO ETF | 8,000 | $402,040 | $403,280 | - | $1,240 | 0.31% | +0.183% |
FBCG Fidelity Blue Chip Growth Fund | 18,163 | $987,885.35 | $1.12M | - | $129,865.67 | 13.15% | -0.533% |
FBND Fidelity Total Bond ETF | 55,170 | $2.54M | $2.42M | - | -$119,898.42 | -4.72% | +0.678% |
FBTC Fidelity Wise Origin Bitcoin Index Fund | 3,142 | $228,245 | $224,275.96 | - | -$3,969.04 | -1.74% | +0.422% |